Michael R. Witten

628 total citations
8 papers, 508 citations indexed

About

Michael R. Witten is a scholar working on Organic Chemistry, Molecular Biology and Materials Chemistry. According to data from OpenAlex, Michael R. Witten has authored 8 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Organic Chemistry, 3 papers in Molecular Biology and 2 papers in Materials Chemistry. Recurrent topics in Michael R. Witten's work include Asymmetric Synthesis and Catalysis (4 papers), Cyclopropane Reaction Mechanisms (4 papers) and Porphyrin and Phthalocyanine Chemistry (2 papers). Michael R. Witten is often cited by papers focused on Asymmetric Synthesis and Catalysis (4 papers), Cyclopropane Reaction Mechanisms (4 papers) and Porphyrin and Phthalocyanine Chemistry (2 papers). Michael R. Witten collaborates with scholars based in United States, Sweden and United Kingdom. Michael R. Witten's co-authors include Eric N. Jacobsen, Noah Z. Burns, Jonathan A. Ellman, Kim Søholm Halskov, Brandon Q. Mercado, Gia L. Hoang, Paramjit S. Arora, Anupam Patgiri, Angus C. Nairn and Jon Read and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Journal of Medicinal Chemistry.

In The Last Decade

Michael R. Witten

8 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael R. Witten United States	7	454	82	79	31	18	8	508
Vishal Jheengut Canada	11	651 1.4×	126 1.5×	124 1.6×	30 1.0×	16 0.9×	14	684
George Borg United States	5	335 0.7×	108 1.3×	121 1.5×	20 0.6×	11 0.6×	9	376
Zhe Zhou United States	12	568 1.3×	120 1.5×	89 1.1×	24 0.8×	18 1.0×	16	609
Darren Stead United Kingdom	10	527 1.2×	107 1.3×	132 1.7×	19 0.6×	13 0.7×	18	587
Mathieu Candy France	10	459 1.0×	59 0.7×	57 0.7×	25 0.8×	10 0.6×	14	485
Fengxia Han China	10	531 1.2×	122 1.5×	50 0.6×	19 0.6×	23 1.3×	10	554
Ying Kit Chung United States	6	538 1.2×	169 2.1×	95 1.2×	33 1.1×	17 0.9×	7	554
Kazutaka Seki Japan	8	484 1.1×	159 1.9×	142 1.8×	33 1.1×	15 0.8×	8	511
И. Р. Рамазанов Russia	11	346 0.8×	63 0.8×	73 0.9×	35 1.1×	7 0.4×	82	382

Countries citing papers authored by Michael R. Witten

Since Specialization

Citations

This map shows the geographic impact of Michael R. Witten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Witten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Witten more than expected).

Fields of papers citing papers by Michael R. Witten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael R. Witten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Witten. The network helps show where Michael R. Witten may publish in the future.

Co-authorship network of co-authors of Michael R. Witten

This figure shows the co-authorship network connecting the top 25 collaborators of Michael R. Witten. A scholar is included among the top collaborators of Michael R. Witten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael R. Witten. Michael R. Witten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Witten, Michael R., Liangxing Wu, Cheng‐Tsung Lai, et al.. (2021). Inhibition of ALK2 with bicyclic pyridyllactams. Bioorganic & Medicinal Chemistry Letters. 55. 128452–128452. 2 indexed citations

Halskov, Kim Søholm, Michael R. Witten, Gia L. Hoang, Brandon Q. Mercado, & Jonathan A. Ellman. (2018). Rhodium(III)-Catalyzed Imidoyl C–H Activation for Annulations to Azolopyrimidines. Organic Letters. 20(8). 2464–2467. 95 indexed citations

Witten, Michael R., Lisa Wissler, Stefan Geschwindner, et al.. (2017). X-ray Characterization and Structure-Based Optimization of Striatal-Enriched Protein Tyrosine Phosphatase Inhibitors. Journal of Medicinal Chemistry. 60(22). 9299–9319. 25 indexed citations

Witten, Michael R. & Eric N. Jacobsen. (2015). A Simple Primary Amine Catalyst for Enantioselective α-Hydroxylations and α-Fluorinations of Branched Aldehydes. Organic Letters. 17(11). 2772–2775. 49 indexed citations

Witten, Michael R. & Eric N. Jacobsen. (2014). Catalytic Asymmetric Synthesis of 8‐Oxabicyclooctanes by Intermolecular [5+2] Pyrylium Cycloadditions. Angewandte Chemie. 126(23). 6022–6026. 24 indexed citations

Witten, Michael R. & Eric N. Jacobsen. (2014). Catalytic Asymmetric Synthesis of 8‐Oxabicyclooctanes by Intermolecular [5+2] Pyrylium Cycloadditions. Angewandte Chemie International Edition. 53(23). 5912–5916. 86 indexed citations

Burns, Noah Z., Michael R. Witten, & Eric N. Jacobsen. (2011). Dual Catalysis in Enantioselective Oxidopyrylium-Based [5 + 2] Cycloadditions. Journal of the American Chemical Society. 133(37). 14578–14581. 195 indexed citations

Patgiri, Anupam, Michael R. Witten, & Paramjit S. Arora. (2010). Solid phase synthesis of hydrogen bond surrogate derived α-helices: resolving the case of a difficult amide coupling. Organic & Biomolecular Chemistry. 8(8). 1773–1773. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact